We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

198 hedge funds and large institutions have $2.69B invested in Ariad Pharmaceuticals Inc in 2013 Q2 according to their latest regulatory filings, with 198 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more call options, than puts

Call options by funds: $16M | Put options by funds: $15.8M

Holders
198
Holders Change
+198
Holders Change %
–
% of All Funds
6.44%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
198
Increased
–
Reduced
–
Closed
–
Calls
$16M
Puts
$15.8M
Net Calls
+$187K
Net Calls Change
+$187K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ARIA Hedge Fund Activity: Q2 2013 in Review

198 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q2 2013, worth a combined $2.69B.

Buyers outnumbered sellers: 198 funds opened new ARIA positions and 0 closed out — a net gain of 198 holders — while 0 added to existing stakes and 0 trimmed.

  • 198 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.69B of Ariad Pharmaceuticals Inc stock for Q2 2013.
  • 198 funds opened new Ariad Pharmaceuticals Inc positions in Q2 2013 and 0 closed out, a net change of +198 holders.

Based on aggregated 13F filings for Q2 2013.